Iraide Alloza Selected Research

Cytokines

2/2021	Novel Transcript Discovery Expands the Repertoire of Pathologically-Associated, Long Non-Coding RNAs in Vascular Smooth Muscle Cells.
1/2018	Inflammation in human carotid atheroma plaques.
1/2012	A 4-trifluoromethyl analogue of celecoxib inhibits arthritis by suppressing innate immune cell activation.
3/2010	Inhibition of secretion of interleukin (IL)-12/IL-23 family cytokines by 4-trifluoromethyl-celecoxib is coupled to degradation via the endoplasmic reticulum stress protein HERP.
3/2006	Multi-chaperone complexes regulate the folding of interferon-gamma in the endoplasmic reticulum.
2/2004	Inhibiting cytokines of the interleukin-12 family: recent advances and novel challenges.
7/2002	The conserved helix C region in the superfamily of interferon-gamma /interleukin-10-related cytokines corresponds to a high-affinity binding site for the HSP70 chaperone DnaK.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Iraide Alloza Research Topics

Disease

6	Multiple Sclerosis 10/2020 - 10/2002
5	Atherosclerotic Plaque (Atheroma) 03/2022 - 01/2017
4	Atherosclerosis 03/2022 - 03/2018
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2016 - 02/2004
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2020
1	Carotid Artery Diseases 03/2018
1	Rupture 01/2018
1	Pathologic Constriction (Stenosis) 01/2014
1	Neuroinflammatory Diseases 01/2013
1	Peritonitis 01/2012
1	Experimental Arthritis 01/2012
1	Arthritis (Polyarthritis) 01/2012
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2010
1	Inflammation (Inflammations) 03/2010
1	Neoplasms (Cancer) 05/2006
1	Fever (Fevers) 03/2006
1	Rheumatoid Arthritis 02/2004
1	Melanoma (Melanoma, Malignant) 07/2002

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 02/2021 - 07/2002
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 07/2002
2	MicroRNAs (MicroRNA)IBA 03/2022 - 01/2022
2	LipidsIBA 03/2022 - 01/2022
2	RNA (Ribonucleic Acid)IBA 02/2021 - 12/2020
2	Celecoxib (Celebrex)FDA Link 01/2013 - 01/2012
2	Interleukin-10 (Interleukin 10)IBA 03/2006 - 07/2002
2	Interleukin-12 (IL 12)IBA 02/2004 - 10/2002
1	CholesterolIBA 01/2022
1	HDL LipoproteinsIBA 01/2022
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2022
1	Long Noncoding RNAIBA 02/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2021
1	Protein Sorting Signals (Signal Peptide)IBA 10/2020
1	LDL Lipoproteins (beta Lipoproteins)IBA 09/2020
1	Transcription Factors (Transcription Factor)IBA 03/2018
1	ChemokinesIBA 01/2018
1	PlasminogenIBA 01/2016
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2013
1	AntibodiesIBA 01/2012
1	CollagenIBA 01/2012
1	Collagen Type II (Type II Collagen)IBA 01/2012
1	Freund's AdjuvantIBA 01/2012
1	Peptides (Polypeptides)IBA 11/2010
1	AutoantigensIBA 11/2010
1	Calcium-Transporting ATPases (Ca2+ ATPase)IBA 05/2006
1	Protein Kinases (Protein Kinase)IBA 05/2006
1	CalreticulinIBA 03/2006
1	NF-kappa B (NF-kB)IBA 02/2004
1	Interleukin-23 (Interleukin 23)IBA 02/2004
1	interleukin 20 (IL-20)IBA 07/2002
1	InterleukinsIBA 07/2002
1	IL-TIF IL-10-related T cell-derived inducible factorIBA 07/2002
1	gamma-AIBA 07/2002

Therapy/Procedure

1	Carotid Endarterectomy 01/2014